In animal models, anti-CTLA4 drugs induce major depletion of regulatory T cells, and mouse model of anti-PD-1 deletion resulted in lupus-like proliferative arthritis and glomerulonephritis [109, 110]. Here, CTLA4 is linked to systemic lupus erythematosus.